Serial changes in norepinephrine kinetics associated with feeding dogs a high-fat diet

Journal of Clinical Hypertension

Volumn 12, Issue 2, 2010, Pages 117-124

  Rocchini, Albert P ^a   Yang, John Q ^a   Smith, Marla J ^a   Supiano, Mark A ^b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARTMENT MODEL; DISTRIBUTION VOLUME; EXPERIMENTAL DOG; EXTRAVASCULAR SPACE; FEMALE; GLUCOSE TRANSPORT; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PLASMA CLEARANCE; PRIORITY JOURNAL; WEIGHT GAIN;

ANALYSIS OF VARIANCE; ANIMALS; DIETARY FATS; DOGS; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; NOREPINEPHRINE; RISK FACTORS; STATISTICS AS TOPIC; SYMPATHETIC NERVOUS SYSTEM; WEIGHT GAIN;

EID: 76049099784     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2009.00230.x     Document Type: Article

References (34)

1. Landsberg L, Young JB. Fasting, feeding and regulation of the sympathetic nervous system. N Engl J Med 1978, 298:1295-1301.
2. Landsberg L. Diet, obesity and hypertension: a hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. QJM 1986, 61:1081-1090.
3. Young JB, MacDonald IA. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obes 1992, 16:959-967.
4. Masuo K, Kawaguchi H, Mikami H. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003, 42:474-480.
5. Masuo K, Mikami H, Ogihara T. Weight gain -induced blood pressure elevation. Hypertension 2000, 35:1135-1140.
6. Esler M, Jennings B, Lambert G. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions. Physiol Rev 1990, 70:936-985.
7. Grassi G, Esler M. How to assess sympathetic activity in humans. J Hypertens 1999, 17:719-734.
8. Coppack SW, Horowitz JF, Paramore DS. Whole body, adipose tissue and forearm norepinephrine kinetics in lean and obese women. Am J Physiol Endocrinol Metab 1998, 275:E830-E834.
9. Vaz M, Jennings G, Turner A. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997, 96:3423-3429.
10. Alvarez GE, Beske SD, Ballard TP. Sympathetic neural activation in visceral obesity. Circulation 2002, 106:2533-2536.
11. Grassi G, Seravalle G, Dell'Oro R. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 2000, 36:538-542.
12. Gudbjornsdottir S, Lonnroth P, Sverrisdottir Y. Sympathetic nerve activity and insulin in obese normotensive and hypertensive men. Hypertension 1996, 27:276-280.
13. Spraul M, Anderson EA, Bogardus C. Muscle sympathetic nerve activity in response to glucose ingestion. Impact of plasma insulin and body fat. Diabetes 1994, 43:191-196.
14. Huggett RJ, Scott EM, Gilbey SG. Disparity of autonomic control in type 2 diabetes mellitus. Diabetolgia 2005, 48:172-179.
15. Katzeff HL, O'Connell M, Horton ES. Metabolic studies in human obesity during overnutrition and undernutrition: thermogenic and hormonal responses to norepinephrine. Metabolism 1986, 35:166-175.
16. Gentile CL, Orr JS, Davy BM. Modest weight gain is associated with sympathetic neural activation in nonobese humans. Am J Physiol Regul Integr Comp Physiol 2007, 292:R1834-R1838.
17. Rocchini AP, Moorehead CS, DeRemer S. Pathogenesis of weight related changes in pressure in the dog. Hypertension 1989, 13:922-928.
18. Rocchini AP, Marker P, Cervenka T. Time course of insulin resistance associated with feeding dogs a high fat diet. Am J Physiol Endocrinol Metab 1997, 272:E147-E154.
19. Evans MI, Halter JB, porte D. Comparison of double- and single- isotope enzymatic derivative methods for measuring catecholamines in human plasma. Clin Chem 1978, 24:567-570.
20. Anton AH, Sayre DF. A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for analysis of catecholamines. J Pharmacol Exp Ther 1962, 138:360-375.
21. Linares OA, Jacquez JA, Zech LA. Norepinephrine metabolism in humans: kinetic analysis and model. J Clin Invest 1987, 80:1332-1341.
22. Berman MW, Beltz F, Grief PC. CONSAAM User's Guide. No. 1983-421:3279 1984, Washington, DC, United States Government Printing Office
23. Berman MW, Weiss MF. SAAM Manual. National institutes of Health Publication No. 78-180 1978, Washington, DC, United States Department of Health, Education, and Welfare
24. Esler M. Assessment of sympathetic nervous system function in humans from noradrenaline plasma kinetics. Clin Sci (Lond) 1982, 62:247-254.
25. Sinaiko AR, Jacobs DR, Steinberger J. Insulin resistance syndrome in childhood: association of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J Pediatr 2001, 139:700-707.
26. Rocchini AP, Moorehead C, Wentz E. Obesity-induced hypertension in the dog. Hypertension 1987, 9(suppl 3):64-68. III
27. Eikelis N, Lambert G, Wiesner G. Extra-adipocyte Leptin release in human obesity and its relation to sympathoadrenal function. Am J Physiol Endocrinol Metab 2004, 286:E744-E752.
28. Bazelmans JP, Nestel K, O'Dea K. Blunted norepinephrine responsiveness to changing energy states in obese subjects. Metabolism 1985, 34:154-160.
29. Schwartz R, Jaeger L, Veith R. The importance of body composition to the increase in palama norepinephrine appearance rate in elderly men. J Gerontol 1987, 42:546-551.
30. Hall JE, Brands MW, Dixon WN. Obesity-induced hypertension: renal function and systemic hemodynamics. Hypertension 1993, 22:292-299.
31. Kassab S, Kato T, Wilkins C. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995, 25:893-897.
32. Rocchini AP, Mao HZ, Babu K. Clonidine prevents insulin resistance and hypertension in obese dogs. Hypertension 1999, 33:548-553.
33. Rocchini AP, Yang Q, Gokee A. Hypertension and insulin resistance are not directly related in obese dogs. Hypertension 2004, 43:1011-1016.
34. Chazova I, Almazov VA, Shlyakhto E. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin. Diabetes Obes Metab 2006, 8:456-465.